Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents

Fig. 3

Platelet count and ALT levels at different time points in all patients with SVR12 (n = 388) (a), those with (n = 204) and without (n = 184) thrombocytopenia who achieved SVR12 (b). ALT, alanine aminotransferase; BA, baseline; 2 W, week 2; 4 W, week 4; EOT, end of therapy; PW12, 12 weeks after direct-acting antiviral therapy

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us